1YTop 25% of the group
Rank 11 of 63 funds
Return +23.08%
1Y returns of 63 funds in the Health Care group, sorted from highest to lowest. This fund ranks 11No. 1 is SCBGENOME(E) +62.13%
TISCO US Healthcare Fund
Shows where this fund stands in its group. Not investment advice · Data as of 3 Nov 2026
TUSHEALTH-A invests through the master fund State Street Health Care Select Sector SPDR ETF (XLV) 98.74%
This fundTUSHEALTH-A
The fund that actually investsSingle listed class (ETF) · United StatesThis fund and the master fund each charge their own fees. See the fees section of this page for the actual fees
Eli Lilly and Co LLY14.91%
Johnson & Johnson JNJ10.28%Data as of 30 Sep 2026 · Top 6 shown, the rest grouped as Other · per the issuer's fact sheet
Over the past year it was in the top 25% of its group; there is no rank for a longer period yet
No. 1 is SCBGENOME(E) +62.13%
Each bar is one fund in the AIMC Health Care group, sorted from highest to lowest return · Every share class is counted, and only funds with a full track record for the period are included · Calculated from NAV as of 3 Nov 2026
Past performance is not a guarantee of future results
| YTD | 1W | 2W | 1M | 3M | 6M | 1Y | MAX |
|---|---|---|---|---|---|---|---|
| +15.29% | +2.54% | +2.21% | +10.27% | +12.34% | +24.22% | +23.08% | +10.64% |
Total return over each period, matching the NAV chart periods · Not annualised
| Year | Jan | Feb | Mar | Apr | May | Jun |
|---|
Largest drawdown in the selected period −19.13% Previous peak 18 Sep 2024 (NAV 9.9797) → Trough 7 Aug 2025 (NAV 8.0706) · Back to the previous peak on 7 Jul 2026, after 11 months
Currently −0.45% from the peak NAV of 11.0917 (30 Oct 2026)
Over 1 year, TUSHEALTH-A returned 1.43 per unit of volatility, ranking 6 of 40 funds · The highest is FP HCARE-A (1.64)
กองทุนจะเน้นลงทุนในหน่วยลงทุนของกองทุน State Street Health Care Select Sector SPDR ETF (กองทุนหลัก) ซึ่งเป็นกองทุนรวมอีทีเอฟ (Exchange Traded Fund) ที่จดทะเบียนซื้อขายในตลาดหลักทรัพย์นิวยอร์ก (New York Stock Exchange, “NYSE Arca”) ประเทศสหรัฐอเมริกา และอยู่ภายใต้การกำกับดูแลของสำนักงานคณะกรรมการกำก… Its largest holdings are STATE STREET HEALTH CARE SELECT SECTOR SPDR ETF 98.74% (fact sheet 30 Sep 2026)
Risk level 7 of 8 (High risk). Since 18 Sep 2024, its NAV has fallen as much as −19.13% from its peak.
Actual total expense ratio (TER) 1.31% a year, against a ceiling of 5.00%. Management fee 1.07%. Front-end fee 1.00%. Back-end fee 0.00%. (Fact sheet 30 Sep 2026)
No. Gains or losses accumulate in the NAV, and investors receive their return when they redeem units
Minimum first purchase 1,000 THB, subsequent purchases 1,000 THB. Buy orders accepted until 15:30, sell orders until 15:30, and redemption proceeds are paid T+3
Hedged at the manager's discretion. As of 30 Sep 2026, 88.99% of the value of its foreign investments was hedged
They are share classes of the same fund and invest in the same assets. They differ only in each class's terms, such as dividend policy, fees or who can buy · TUSHEALTH-A: no dividends, TER 1.31% · TUSHEALTH-SSF: no dividends, TER 1.35%
Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
ABBVIE ABBV
Merck & MRK5.77%
Unitedhealth Group UNH5.31%
Thermo Fisher TMO4.02%
Amgen AMGN3.67%
Gilead Sciences GILD2.98%
Abbott Laboratories ABT2.75%
Pfizer PFE2.62%Eli Lilly and Co LLYDiabetes and weight-loss drugs
An American medicines and medical devices company, with products such as cancer drugs and surgical instruments
ABBVIE ABBVHospitals, medicines and medical equipment
Merck & MRKHospitals, medicines and medical equipment
Hospitals, medicines and medical equipment
Thermo Fisher TMOAn American company selling scientific instruments, reagents and services for laboratories
Amgen AMGNHospitals, medicines and medical equipment
Gilead Sciences GILDA US drug company making HIV treatment and prevention drugs, hepatitis drugs and cancer drugs
Hospitals, medicines and medical equipment
Pfizer PFEHospitals, medicines and medical equipment
Based on the master fund's share of this fund's value (98.74% as of 30 Sep 2026) × each stock's weight in the master fund · stocks as of 22 Oct 2026 · Illustrations are for explanation only, not individual stock recommendations
| Jul |
|---|
| Aug |
|---|
| Sep |
|---|
| Oct |
|---|
| Nov |
|---|
| Dec |
|---|
| Full year |
|---|
| 2026 | −1.0 | +3.0 | −8.0 | −1.1 | +2.0 | +6.5 | +2.0 | +4.2 | −1.1 | +9.3 | −0.4 | · | +15.3* |
| 2025 | +6.2 | +1.3 | −1.7 | −4.4 | −6.1 | +1.5 | −3.4 | +4.9 | +1.3 | +3.2 | +8.7 | −1.6 | +9.3 |
| 2024 | · | · | · | · | · | · | · | · | −1.7 | −4.2 | +0.1 | −6.8 | −12.2* |